P Gascon

发表

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy.

M. Piccart, J. Baselga, P. Gascón, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study

M. Piccart, J. Baselga, F. Cardoso, 2008, British Journal of Cancer.